Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: mappingworld who wrote (1598)	4/6/1999 6:37:00 PM
From: the Chief	Respond to of 14101

Well, from my past experience (which is limited) in a stock called IGT pharma, you can jump on these biotechs to early, way-y-y-y to early!! Thats what I did with IGT. DMX is a kettle of different fish. The longterm holders have/had gone through all the company bullship about approvals just around the corner for over two yars now. According to my HC/UK/US-FDA spy, the timing is perfect for DMX. 2 years in the Canuck system and over 1 year in the UK/USA virtually guarantees some sort of priority level. In this late stage 'the odds" are you are at the top of the list and you are seriously being processed. There are no guarantees in life, but I put a little BII money in this guy over the last few days, and will continue to pick it up around the 3.00-15 level. the Chief